JP2025504374A5 - - Google Patents
Info
- Publication number
- JP2025504374A5 JP2025504374A5 JP2024540866A JP2024540866A JP2025504374A5 JP 2025504374 A5 JP2025504374 A5 JP 2025504374A5 JP 2024540866 A JP2024540866 A JP 2024540866A JP 2024540866 A JP2024540866 A JP 2024540866A JP 2025504374 A5 JP2025504374 A5 JP 2025504374A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- disease
- independently
- disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263297444P | 2022-01-07 | 2022-01-07 | |
| US63/297,444 | 2022-01-07 | ||
| PCT/US2023/010314 WO2023133271A1 (en) | 2022-01-07 | 2023-01-06 | Bicyclic phthalazin-1(2h)-one derivatives and related uses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025504374A JP2025504374A (ja) | 2025-02-12 |
| JP2025504374A5 true JP2025504374A5 (enExample) | 2025-12-18 |
Family
ID=85239129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024540866A Pending JP2025504374A (ja) | 2022-01-07 | 2023-01-06 | 二環式フタラジン－１（２ｈ）－オン誘導体および関連する使用法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250066369A1 (enExample) |
| EP (1) | EP4460505A1 (enExample) |
| JP (1) | JP2025504374A (enExample) |
| KR (1) | KR20240145992A (enExample) |
| CN (1) | CN118922421A (enExample) |
| AU (1) | AU2023205048A1 (enExample) |
| CA (1) | CA3247232A1 (enExample) |
| IL (1) | IL314035A (enExample) |
| MX (1) | MX2024008477A (enExample) |
| WO (1) | WO2023133271A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025153532A1 (en) * | 2024-01-16 | 2025-07-24 | NodThera Limited | Nlrp3 inhibitors and glp-1 agonists combination therapies |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| RU2364597C1 (ru) * | 2007-12-14 | 2009-08-20 | Андрей Александрович Иващенко | ГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ Hh-СИГНАЛЬНОГО КАСКАДА, ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ И СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С АББЕРАНТНОЙ АКТИВНОСТЬЮ Hh СИГНАЛЬНОЙ СИСТЕМЫ |
| US20240043450A1 (en) * | 2020-09-24 | 2024-02-08 | Janssen Pharmaceutica Nv | New compound |
-
2023
- 2023-01-06 JP JP2024540866A patent/JP2025504374A/ja active Pending
- 2023-01-06 EP EP23705320.2A patent/EP4460505A1/en active Pending
- 2023-01-06 AU AU2023205048A patent/AU2023205048A1/en active Pending
- 2023-01-06 US US18/726,919 patent/US20250066369A1/en active Pending
- 2023-01-06 KR KR1020247026276A patent/KR20240145992A/ko active Pending
- 2023-01-06 IL IL314035A patent/IL314035A/en unknown
- 2023-01-06 MX MX2024008477A patent/MX2024008477A/es unknown
- 2023-01-06 WO PCT/US2023/010314 patent/WO2023133271A1/en not_active Ceased
- 2023-01-06 CN CN202380025701.8A patent/CN118922421A/zh active Pending
- 2023-01-06 CA CA3247232A patent/CA3247232A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023540733A5 (enExample) | ||
| KR20230057411A (ko) | 바이러스 감염 치료를 위한 화합물 및 방법 | |
| CN114174303B (zh) | 作为sting激动剂的大环化合物及其方法和用途 | |
| JP2021534124A5 (enExample) | ||
| JP2021523159A5 (enExample) | ||
| JP2022536160A5 (enExample) | ||
| HRP20250964T1 (hr) | Derivati sulfonil ureje kao modulatori nlrp3 inflamasoma | |
| JP2023540344A5 (enExample) | ||
| JP2019520417A5 (enExample) | ||
| JP2016525130A5 (enExample) | ||
| JP2020528889A5 (enExample) | ||
| JP2019519598A5 (enExample) | ||
| JP2011523412A5 (enExample) | ||
| JP2018531289A5 (enExample) | ||
| JP2016500661A5 (enExample) | ||
| JP2013522232A5 (enExample) | ||
| JP2020518571A5 (enExample) | ||
| JP2025504374A5 (enExample) | ||
| JP2022535956A5 (enExample) | ||
| JP2020503332A5 (enExample) | ||
| JP2022535955A5 (enExample) | ||
| HRP20240896T1 (hr) | Derivati sulfoniluree i njihova upotreba | |
| JP2022522890A5 (enExample) | ||
| CN110049768B (zh) | 酚噻嗪衍生物及其使用方法 | |
| JP2022518526A5 (enExample) |